Factors Predictive of Glomerular Hyperfiltration in Sickle-Cell Anemia Males
- 1 Nephrology Department of CHU Sylvanus Olympio, University of Lomé, Lomé, Togo
- 2 Nephrology Department of CHU Kara, University of Kara, Kara, Togo
- 3 Nephrology Department of CHU Sylvanus Olympio, University of Lomé, Lomé, Togo
- 4 Nephrology Department of CHU Sylvanus Olympio, University of Lomé, Lomé, Togo
- 5 Nephrology Department of CHR Lome Commune, University of Lomé, Lomé, Togo
- 6 Nephrology Department of CHU Sylvanus Olympio, University of Lomé, Lomé, Togo
Abstract
Background: Renal manifestations, including glomerular hyperfiltration during sickle cell disease (SCD), are very frequent and constitute the starting point for renal failure. Few data are available on this subject in Togo. The aim of this study was to describe the predictive factors of glomerular hyperfiltration in SCD in our Togolese context. Methods: This was a retrospective descriptive and analytical study carried out at the Centre National de Recherche et de Soins aux Drépanocytaires du Togo located in the commune of Lomé. Hyperfiltration was defined for all major sickle cell patients by a glomerular filtration rate (GFR) > 130 ml/min/1.73m 2 and renal failure by a GFR < 60 ml/min/1.73m 2 calculated according to the Modification of Diet in Renal Disease (MDRD) equation. We investigated factors associated with glomerular hyperfiltration using univariate and multivariate logistic regression. The dependent variable was GFR status > 130 coded 1 and 0 if not. Results: 82.0% of major sickle cell patients had glomerular hyperfiltration, and 1.7% were in renal failure. The mean age of our patients was 14.1 years, with a female predominance of 53.2%, giving a sex ratio (M/F) of 0.88. Homozygous sickle cell patients represented 55.3% of the population and heterozygous SC 38.5%. In a comparative analysis, there was a statistically significant difference between the proportion of patients with and without glomerular hyperfiltration according to age (p < 0.001), gender (p < 0.001), economic activity (p < 0.001), marital status (p < 0.001), educational level (p = 0.007), hemoglobin phenotype (p < 0.001), proportion of HbS (p < 0.001); to certain circumstances of discovery as painful crises (p = 0.002), infection (p < 0.001), hand-foot syndrome (p = 0.015) and asthenia (p = 0.032); of certain complications as occurrence of at least one complication (p = 0.025), anemia (p = 0.003), priapism (p = 0.048), renal failure (p = 0.001), osteonecrosis (p = 0.041) and retinopathy (p = 0.001). Risk factors for hyperfiltration were male gender (p = 0.016), age under 10 years (p = 0.001), age between 10 and 19 years (p < 0.001), hemoglobin S > 70% (p = 0.009) and low azotemia (p = 0.004). Conclusion: Glomerular hyperfiltration is very frequent in sickle cell disease syndromes in Togo, with a non-negligible presence of renal failure. Risk factors are dominated by a young age, as in the literature.
- de Montalembert, M. and Girot, R. (2013) Sickle Cell Disease in Children. EMC — Pédiatrie — Maladies infectieuses , 8, 1-9.
- Rees, D.C., Williams, T.N. and Gladwin, M.T. (2010) Sickle-Cell Disease. The Lancet , 376, 2018-2031. https://doi.org/10.1016/s0140-6736(10)61029-x
- Segbena, A.Y., Kueviakoe, I.M.D. and Messie, A.K. (2005) Situation of Sickle Cell Disease in Togo. Journal de la Recherche Scientifique de l ’ Université de Lomé , 7, 203-205.
- Segbena, A.Y., Kueviakoe, I., Messie, A.K., Napo-Koura, I.G., Vovor, A. and David, M. (2002) Hemo-Globin Abnormalities at the Centre Hospitalier Universitaire De Lomé, Togo. Médecine Tropicale , 62, 51-54.
- Garba, M., Moussa Tondi, Z.M., Diongoule, H., Aboubacar, S., Ide, A., Biyao-Nelson, N.R., et al . (2018) Screening for Nephropathy in Major Sickle Cell Syndromes in Patients Followed at the National Reference Center for Sickle Cell Disease in Niamey, Niger. Néphrologie & Thérapeutique , 14, 462-466. https://doi.org/10.1016/j.nephro.2017.11.002
- Cazenave, M., Koehl, B., Nochy, D., Tharaux, P. and Audard, V. (2014) Renal Impairment in Sickle Cell Disease. Néphrologie & Thérapeutique , 10, 10-16. https://doi.org/10.1016/j.nephro.2013.07.366
- Pondarré, C. (2008) Renal Monitoring in Sickle Cell Disease. Médecine Thérapeutique Pédiatrie , 11, 47-51.
- Joyce, I.N., Caroline, B., Marilyn, M. and Inusa, P.D.B. (2021) Evaluation of Glomerular Hyperfiltration and Albuminuria in Sickle Cell Disease Adolescents: Cross-Sectional Retrospective Study. Open Journal of Nephrology , 11, 321-334. https://doi.org/10.4236/ojneph.2021.113026
- Fiawoo, M., Douti, N.K., Agbeko, F., Guedenon, K.M., Takassi, O.E., Akolly, D.A.E., et al . (2020) Acute Complications of Sickle Cell Disease in Hospitalized Children in Togo. Journal de la Recherche Scientifique de l ’ Université de Lomé , 22, 683-690.
- Akolly Djatougbé, A.E., Djadou, K.E., Guedenon, K.M., Tsolenyanu, E., Agbenu, S., Douti, N.L., et al . (2021) Hospital Morbidity of the Sickle Cell Child at CHU Sylvanus Olympio (Lomé). Health Sciences and Disease , 22, 9-13.
- Agbeko, F., Fiawoo, M., Tchagbele, O.B., Azoumah, K., Gbadoe, A.D. and Agbere, A.D. (2017) Clinical and Biological Profiles of Sickle Cell Major Syndrome in Sokodé in the Central Region of Togo. Journal africain de pédiatrie et de génétique médicale , 2, 54-58.
- Guedenon, K.M., Gbadoe, A.D. and Nouwakpo, N.B. (2015) Gross Hematuria in Sickle Cell Disease at Tokoin Teaching Hospital in Lomé (Togo). Médecine et Santé Tropicales , 25, 432-433. https://doi.org/10.1684/mst.2014.0431